0001555280-26-000024
SEC filingModest revenue and gross profit growth from livestock strength offset companion animal declines, yielding stable margins but pressured net income and operating cash flow due to inventory builds and payment timing.
Zoetis delivered revenue of $2.3 billion in Q1 FY2026, a 1.9% increase from $2.2 billion in the prior year, driven by livestock revenue growth primarily from increased demand for cattle, poultry, and swine products. Sales of cattle products specifically grew due to a mix of volume and price, helping offset declines in companion animal revenue caused by softer end-market demand and an increasingly competitive landscape. This dynamic underscores Zoetis' diversified portfolio across companion animals and livestock, enabling the company to capitalize on local and regional trends and customer needs within its operating segments.
Gross profit rose 1.4% to $1.6 billion, maintaining a healthy 71.7% margin. This stability reflects Zoetis' ability to manage costs effectively despite segment-specific pressures, with livestock momentum providing a buffer against companion animal headwinds. Net income, however, declined 4.8% to $601 million from $631 million, highlighting the impact of competitive dynamics in key companion animal categories even as topline growth persisted.
Operational cash flow fell to $401 million from $587 million, primarily attributable to the timing of receipts and payments in the ordinary course of business, coupled with higher inventory build-up for certain products. This was partially offset by higher net income adjusted for non-cash items and the timing of income tax payments. Capital expenditures decreased to $110 million from $149 million, resulting in free cash flow of $291 million and demonstrating disciplined investment amid cash generation challenges.
These results reflect Zoetis' strategic positioning in animal health, where livestock strength compensates for companion animal softness. Management notes that challenging economic conditions have not significantly impacted liquidity, supporting ongoing operations. Investors should monitor inventory normalization and cash flow timing for potential recovery, as well as sustained livestock demand amid competition risks. The company's focus on diverse products positions it to navigate these dynamics while maintaining margin resilience.